Related Experiment Video
Updated: May 10, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
Published on: March 3, 2015
Rational engineering of isoform-specific hSULT1E1 fluorogenic substrates for functional analysis and inhibitor
Xiaoting Niu1, Yufan Fan1, Guanghao Zhu1
1Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Researchers engineered a novel fluorogenic substrate, HN-375, for human estrogen sulfotransferase (hSULT1E1). This tool enables sensitive detection of enzyme activity in cancer and facilitates high-throughput screening for hSULT1E1 inhibitors.
Area of Science:
- Biochemistry and Molecular Biology
- Enzyme Engineering
- Drug Discovery
Background:
- Human estrogen sulfotransferase (hSULT1E1) is vital for estrogen homeostasis and metabolizing foreign compounds.
- Developing specific tools to study hSULT1E1 activity is crucial for understanding its role in health and disease.
Purpose of the Study:
- To rationally design and synthesize highly specific fluorogenic substrates for hSULT1E1.
- To establish a sensitive assay for measuring hSULT1E1 activity and screening for inhibitors.
Main Methods:
- Structure-based virtual screening identified 4-hydroxyl-1,8-naphthalimide as a scaffold.
- Iterative structural modifications led to the development of HN-375, a selective and reactive substrate.
- Fluorescence-based assays were employed for activity detection and inhibitor screening.
Main Results:
- HN-375 was synthesized and demonstrated high specificity and sensitivity for hSULT1E1.
- The substrate produced a bright green fluorescent signal (510 nm) upon sulfation, forming HN-375 4-O-sulfate.
- HN-375 enabled sensing of hSULT1E1 activity in hepatocellular carcinoma specimens and live organs, and facilitated the identification of two potent inhibitors.
Conclusions:
- A groundbreaking strategy for engineering specific fluorogenic substrates for conjugative enzymes was developed.
- HN-375 is a practical tool for sensing hSULT1E1 activity in biological contexts.
- The developed assay supports high-throughput screening of hSULT1E1 inhibitors for potential therapeutic applications.
Related Concept Videos
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

